World Health Organization (WHO) and the European Union launch collaboration to advance digitized health systems in ...

Crystal Palace continued their impressive start to the season with a new club record as they opened their Conference League campaign with a comfortable victory against Dynamo Kyiv in Poland. Daniel ...

Investing.com -- European healthcare shares jumped on Wednesday after Pfizer reached a deal with the U.S. government to lower prescription drug prices in exchange for tariff relief, easing some of the ...

LONDON (Reuters) -European healthcare stocks jumped on Wednesday, mirroring moves in the United States, propelled by a deal between Pfizer and President Donald Trump to lower prescription drug prices ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Your period can be a powerful indicator of your overall ...

Our community is split on government plans for a compulsory digital ‘Brit card’. While some warned it would erode civil ...

When the EU entry-exit system takes effect on 12 October, the French government will challenge British travellers to comply ...

(Reuters) -European stocks were dragged down by med-tech shares on Thursday after the U.S. launched fresh import probes, while investors sifted through comments from Federal Reserve officials and ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — Regulators in Europe have issued new statements backing the ...

The "European Cards and Payments Report 2025" has been added to ResearchAndMarkets.com's offering. The European Regional Overview provides a pan-European perspective on digital and card payments ...

The next rally in European stocks could be around the corner, as positive signs are emerging sooner than expected, equity strategists at UBS said in a research note. Recent economic indicators point ...

AFTER IMPOSING tariffs on European drug exports this summer, Donald Trump wrote to the heads of 17 big pharmaceutical firms, demanding that American prices be brought into line with the lower prices ...